Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function
Insurers Promise to Speed Up Delays in Health Care Approvals
Biomarker Panel Improves Prediction of CKD Progression in Children
Urine/creatinine was the variable with the highest importance and ID'd highest risk group when combined with urine epidermal growth factor/creatinine
FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Worse Outcomes Seen for Unvaccinated Patients Hospitalized With COVID-19, AKI
Unvaccinated patients had higher rate of continuous renal replacement therapy during hospitalization and higher rate of being discharged on RRT
Electronic Nudge Letters Do Not Improve Guideline-Directed Medical Therapy in CKD
Neither electronic nudge letters nor letters to general practice increase uptake of GDMT
Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis
Decrease in survival benefits with age in expanded criteria donor kidney transplant recipients, especially those with CVD
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
Greater reduction in urinary albumin-to-creatinine ratio seen for combination versus either agent alone
Early, Preemptive Kidney Transplant No Aid to Mortality
Rates of preemptive kidney transplants remained at ~18 percent of total kidney transplants from 2000 to 2020
